ArticleJMIR AI2025
Use of Automated Machine Learning to Detect Undiagnosed Diabetes in US Adults: Development and Validation Study.
Article in JMIR AI, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Early diagnosis of diabetes is essential for early interventions to slow the progression of dysglycemia and its comorbidities. However, among individuals with diabetes, about 23% were unaware of their condition. Objective: This study aims to investigate the potential use of automated machine learning (AutoML) models and self-reported data in detecting undiagnosed diabetes among US adults. Methods: Individual-level data, including biochemical tests for diabetes, demographic characteristics, family history of diabetes, anthropometric measures, dietary intakes, health behaviors, and chronic conditions, were retrieved from the National Health and Nutrition Examination Survey, 1999-2020. Undiagnosed diabetes was defined as having no prior self-reported diagnosis but meeting diagnostic criteria for elevated hemoglobin A1c, fasting plasma glucose, or 2-hour plasma glucose. The H2O AutoML framework, which allows for automated hyperparameter tuning, model selection, and ensemble learning, was used to automate the machine learning workflow. For comparative analysis, 4 traditional machine learning models-logistic regression, support vector machines, random forest, and extreme gradient boosting-were implemented. Model performance was evaluated using the area under the receiver operating characteristic curve. Results: The study included 11,815 participants aged 20 years and older, comprising 2256 patients with undiagnosed diabetes and 9559 without diabetes. The average age was 59.76 (SD 15.0) years for participants with undiagnosed diabetes and 46.78 (SD 17.2) years for those without diabetes. The AutoML model demonstrated superior performance compared with the 4 traditional machine learning models. The trained AutoML model achieved an area under the receiver operating characteristic curve of 0.909 (95% CI 0.897-0.921) in the test set. The model demonstrated a sensitivity of 70.26%, specificity of 90.46%, positive predictive value of 64.10%, and negative predictive value of 92.61% for identifying undiagnosed diabetes from nondiabetes. Conclusions: To our knowledge, this study is the first to utilize the AutoML model for detecting undiagnosed diabetes in US adults. The model's strong performance and applicability to the broader US population make it a promising tool for large-scale diabetes screening efforts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.